Drug profile · INN
thiethylperazine maleate
TORECAN
thiethylperazine maleate (TORECAN) is a dopamine d2 receptor antagonist. Route of administration: rectal. Current US regulatory status: approved.
Drug details — thiethylperazine maleate
- US status
- approved
- Class
- —
- Route
- RECTAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
thiethylperazine maleate (TORECAN) is a dopamine d2 receptor antagonist. Route of administration: rectal. Current US regulatory status: approved.
Key facts
Mechanism of action
Dopamine D2 receptor antagonist
Primary target: D(2) dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is thiethylperazine maleate?
thiethylperazine maleate (TORECAN) is a dopamine d2 receptor antagonist. Route of administration: rectal. Current US regulatory status: approved.
What is the brand name for thiethylperazine maleate?
TORECAN is a marketed brand name for thiethylperazine maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of thiethylperazine maleate?
thiethylperazine maleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.